pimecrolimus FDA Link

an ascomycin derivative; mechanism of action involves calcineurin inhibition, blockage of T cell activation, blocking signal transduction pathways in T cells, and inhibition of the synthesis of inflammatory cytokines, specifically Th1- and Th2-type cytokines

Also Known As:

Elidel; 33-epi-chloro-33-desoxyascomycin; ASM 981; SDZ ASM 981; SDZ-ASM-981

Pharmalogical Action Categories:

D000894 - Anti-Inflammatory Agents, Non-Steroidal
D003879 - Dermatologic Agents
D007166 - Immunosuppressive Agents

Organic Chemicals: 140
- Lactones: 1590
  - Macrolides: 4461
    - Tacrolimus: 7980
      - pimecrolimus: 605

Danijela Milcic Selected Research

Danijela Milcic Research Topics

Disease

Drug/Important Bio-Agent (IBA)